Common side effects include nausea, vomiting, diarrhoea and constipation
Medical and dental practitioners should be aware of possible oral mucosal hyperpigmentation in patients taking imatinib mesylate
Swiss Chems Provider Profile Name: Swiss Chems Website: swisschems.com Founded: August 2018 Provider Type: Research Peptide Vendor FDA Warning Letter: December 10, 2024 Operating Details E-commerce peptide vendor Received an FDA warning letter in December 2024 after an investigation found the company was selling semaglutide and retatrutide products for human use despite marketing them for research and chemical purposes No prescription required for purchase Products sold as freeze-dried powders requiring reconstitution About the Company Swiss Chems was among the companies targeted in the FDAs December 2024 enforcement wave, alongside Xcel Peptides, Summit Research, and Prime Peptides, all found to be selling semaglutide, tirzepatide, and/or retatrutide for human use despite marketing the drugs for research and chemical purposes
You might be experiencing a Vitamin B12 deficiency
Inhibition of the DPP-4 enzyme prolongs and enhances the activity of incretins that play an important role in insulin secretion and blood glucose control regulation
To avoid these issues, always store semaglutide at the recommended temperatures and conditions
